Pat | 2 days | 7 days | 14 days | P-value | ||||
---|---|---|---|---|---|---|---|---|
n | Risk | n | Risk | n | Risk | |||
Age <60 years | 19 | 1 | 5% (0-15%) | 1 | 5% (0-15%) | 2 | 11% (0-25%) | p = 0.95 |
Age ≥60 years | 211 | 11 | 5% (2-8%) | 17 | 8% (4-12%) | 23 | 11% (7-16%) | |
Blood Pressure <140/90 | 46 | 5 | 11% (2-20%) | 7 | 15% (5-26%) | 8 | 17% (6-28%) | p = 0.10 |
Blood Pressure ≥140/90 | 184 | 7 | 4% (1-7%) | 11 | 6% (2-10%) | 17 | 10% (5-14%) | |
Clinical presentation: Other | 64 | 2 | 3% (0-7%) | 2 | 3% (0-7%) | 2 | 3% (0-7%) | p = 0.06 |
Clinical presentation: Speech disturbance | 17 | 1 | 6% (0-17%) | 3 | 18% (0-37%) | 3 | 18% (0-37%) | |
Clinical presentation: Focal weakness | 149 | 9 | 6% (2-10%) | 13 | 9% (4-13%) | 20 | 14% (8-20%) | |
Duration <10 min* | 59 | 2 | 3% (0-8%) | 2 | 3% (0-8%) | 4 | 7% (0-14%) | p = 0.45 |
Duration 10-59 min* | 36 | 2 | 6% (0-13%) | 5 | 14% (3-25%) | 5 | 14% (3-25%) | |
Duration ≥60 min* | 130 | 8 | 6% (2-10%) | 11 | 9% (4-13%) | 16 | 13% (7-18%) | |
Diabetes: Absent | 168 | 9 | 5% (2-9%) | 13 | 8% (4-12%) | 18 | 11% (6-16%) | p = 0.91 |
Diabetes: Present | 62 | 3 | 5% (0-10%) | 5 | 8% (1-15%) | 7 | 12% (3-20%) | |
Dual events: Absent | 183 | 10 | 5% (2-9%) | 14 | 8% (4-12%) | 19 | 11% (6-15%) | p = 0.61 |
Dual events: Present | 47 | 2 | 4% (0-10%) | 4 | 9% (0-17%) | 6 | 14% (3-25%) |